BYETTA is a non-insulin type 2 diabetes injection medication for adults. Important Safety Information for BYETTA (exenatide) injection . with prior severe hypersensitivity reactions to exenatide or to any of the product components. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution for injection in pre-filled pen exenatide. Read all of this leaflet carefully.
|Published (Last):||20 January 2012|
|PDF File Size:||20.99 Mb|
|ePub File Size:||2.12 Mb|
|Price:||Free* [*Free Regsitration Required]|
Pen-sharing poses a risk for transmission of blood-borne pathogens, even if the needle is changed. AstraZeneca provides this link as a service to website visitors.
Type 2 Diabetes Medication | BYETTA® (exenatide) injection
These may be symptoms of pancreatitis. Because exenatide is commonly associated with gastrointestinal adverse reactions, BYETTA is not recommended in patients with severe gastrointestinal disease eg gastroparesis.
The site you are about to visit is maintained by a third party who is solely responsible for its contents.
Symptoms of a severe allergic reaction include severe rash or itching, swelling of your face, lips, and throat that may cause difficulty breathing or swallowing, feeling faint or dizzy and very rapid heartbeat. BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
This site is intended for US Consumers.
Staying Active Learn how regular physical activity can help you manage type 2 diabetes. Stop taking BYETTA and call your healthcare provider right away if you have pain in your stomach area abdomen that is severe, and will not go away, occurs with or without vomiting or is felt going from your abdomen through to your back.
Tell your healthcare provider if you are pregnant or plan to become pregnant. No placebo-treated patients withdrew due to nausea or vomiting. All other trademarks are property of their respective owners. BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise. If worsening of or failure to achieve adequate glycemic control occurs, consider alternative antidiabetic therapy.
It is unknown whether patients with a history of pancreatitis are at increased risk for pancreatitis while using BYETTA; consider other antidiabetic therapies for these patients.
Your risk for getting low blood sugar hypoglycemia is higher if you take BYETTA with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis.
Welcome to BYETTA.com!
Approved Uses BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.
Tell your healthcare provider if you have or had kidney problems or a kidney transplant. Inflammation of the pancreas pancreatitis may happen, which may be severe and lead to death. Call your healthcare provider right away if you have nausea, vomiting, or diarrhea that will not go away, or if you cannot take liquids by mouth. Postmarketing reports of altered renal function, including increased serum creatinine, renal impairment, worsened chronic renal failure, and acute renal failure, sometimes requiring hemodialysis and kidney transplantation.
Use with caution with medications that have a narrow therapeutic index or require rapid gastrointestinal absorption. Patients may develop antibodies to exenatide. You may report side effects related to AstraZeneca products by clicking here. Drug Interactions Oral Medications: Write your html here BYETTA should not be used in people with type 1 diabetes or people with diabetic ketoacidosis a condition caused by very high blood sugar.
If pancreatitis is suspected, BYETTA should be discontinued promptly exeantide should not be restarted if pancreatitis is confirmed. The Double B logo is a trademark of the AstraZeneca group of companies. Postmarketing reports of serious hypersensitivity reactions eg anaphylaxis and angioedema. Before taking BYETTA, tell your healthcare provider if you have had pancreatitis, stones in your gallbladder gallstonesa history of alcoholism, or high blood triglyceride levels.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
All other trademarks are property of their respective owners. Based on animal data, BYETTA may cause fetal harm and should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.